Literature DB >> 12069993

Comparative in vitro sensitivities of human immune cell lines, vaginal and cervical epithelial cell lines, and primary cells to candidate microbicides nonoxynol 9, C31G, and sodium dodecyl sulfate.

Fred C Krebs1, Shendra R Miller, Bradley J Catalone, Raina Fichorova, Deborah Anderson, Daniel Malamud, Mary K Howett, Brian Wigdahl.   

Abstract

In experiments to assess the in vitro impact of the candidate microbicides nonoxynol 9 (N-9), C31G, and sodium dodecyl sulfate (SDS) on human immune and epithelial cell viability, cell lines and primary cell populations of lymphocytic and monocytic origin were generally shown to be equally sensitive to exposures ranging from 10 min to 48 h. However, U-937 cells were more sensitive to N-9 and C31G after 48 h than were primary monocyte-derived macrophages. Cytokine activation of monocytes and lymphocytes had no effect on cell viability following exposure to these microbicidal compounds. Primary and passaged vaginal epithelial cultures and cell lines differed in sensitivity to N-9 and C31G but not SDS. These studies provide a foundation for in vitro experiments in which cell lines of human immune and epithelial origin can be used as suitable surrogates for primary cells to further investigate the effects of microbicides on cell metabolism, membrane composition, and integrity and the effects of cell type, proliferation, and differentiation on microbicide sensitivity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069993      PMCID: PMC127292          DOI: 10.1128/AAC.46.7.2292-2298.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

1.  Assessment of the anti-microbial agent C31G as a spermicide: comparison with nonoxynol-9.

Authors:  K A Thompson; D Malamud; B T Storey
Journal:  Contraception       Date:  1996-05       Impact factor: 3.375

2.  In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses.

Authors:  J Piret; J Lamontagne; J Bestman-Smith; S Roy; P Gourde; A Désormeaux; R F Omar; J Juhász; M G Bergeron
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2.

Authors:  K Z Bourne; N Bourne; S F Reising; L R Stanberry
Journal:  Antiviral Res       Date:  1999-07       Impact factor: 5.970

4.  Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate.

Authors:  F C Krebs; S R Miller; D Malamud; M K Howett; B Wigdahl
Journal:  Antiviral Res       Date:  1999-10       Impact factor: 5.970

5.  Tests of vaginal microbicides in the mouse genital herpes model.

Authors:  L Zeitlin; K J Whaley; T A Hegarty; T R Moench; R A Cone
Journal:  Contraception       Date:  1997-11       Impact factor: 3.375

6.  Organotypic raft cultures for the in vitro evaluation of vaginal microbicidal agents. Microbicides have epithelium-specific effects when repeatedly added onto organotypic human keratinocyte cultures.

Authors:  F Aebischer; J K McDougall
Journal:  Sex Transm Dis       Date:  1997-02       Impact factor: 2.830

7.  Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.

Authors:  M K Stafford; H Ward; A Flanagan; I J Rosenstein; D Taylor-Robinson; J R Smith; J Weber; V S Kitchen
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-04-01

8.  A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.

Authors:  R E Roddy; L Zekeng; K A Ryan; U Tamoufé; S S Weir; E L Wong
Journal:  N Engl J Med       Date:  1998-08-20       Impact factor: 91.245

9.  A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses.

Authors:  M K Howett; E B Neely; N D Christensen; B Wigdahl; F C Krebs; D Malamud; S D Patrick; M D Pickel; P A Welsh; C A Reed; M G Ward; L R Budgeon; J W Kreider
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

Review 10.  Female condoms.

Authors:  W Bounds
Journal:  Eur J Contracept Reprod Health Care       Date:  1997-06       Impact factor: 1.848

View more
  18 in total

1.  In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides.

Authors:  Youssef Gali; Olivier Delezay; Joachim Brouwers; Noura Addad; Patrick Augustijns; Thomas Bourlet; Hind Hamzeh-Cognasse; Kevin K Ariën; Bruno Pozzetto; Guido Vanham
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

2.  Comparative safety evaluation of the candidate vaginal microbicide C31G.

Authors:  Bradley J Catalone; Tina M Kish-Catalone; Elizabeth B Neely; Lynn R Budgeon; Mary L Ferguson; Catherine Stiller; Shendra R Miller; Daniel Malamud; Fred C Krebs; Mary K Howett; Brian Wigdahl
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

3.  Reduced Cationic Nanoparticle Cytotoxicity Based on Serum Masking of Surface Potential.

Authors:  Kellie I McConnell; Sabeel Shamsudeen; Ismail M Meraz; Thiruvillamalai S Mahadevan; Arturas Ziemys; Paul Rees; Huw D Summers; Rita E Serda
Journal:  J Biomed Nanotechnol       Date:  2016-01       Impact factor: 4.099

4.  Multivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors.

Authors:  Julie I Jay; Bonnie E Lai; David G Myszka; Alamelu Mahalingam; Kris Langheinrich; David F Katz; Patrick F Kiser
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

5.  Polyanionic microbicides modify Toll-like receptor-mediated cervicovaginal immune responses.

Authors:  R T Trifonova; G F Doncel; R N Fichorova
Journal:  Antimicrob Agents Chemother       Date:  2009-01-12       Impact factor: 5.191

6.  Structural details and composition of Trichomonas vaginalis lipophosphoglycan in relevance to the epithelial immune function.

Authors:  Bibhuti N Singh; Gary R Hayes; John J Lucas; Ulf Sommer; Nelly Viseux; Ekaterina Mirgorodskaya; Radiana T Trifonova; Rosaria Rita S Sassi; Catherine E Costello; Raina N Fichorova
Journal:  Glycoconj J       Date:  2008-07-06       Impact factor: 2.916

7.  Preformulation studies of EFdA, a novel nucleoside reverse transcriptase inhibitor for HIV prevention.

Authors:  Wei Zhang; Michael A Parniak; Hiroaki Mitsuya; Stefan G Sarafianos; Phillip W Graebing; Lisa C Rohan
Journal:  Drug Dev Ind Pharm       Date:  2013-07-10       Impact factor: 3.225

8.  Poly(ethylene glycol) (PEG)-lactic acid nanocarrier-based degradable hydrogels for restoring the vaginal microenvironment.

Authors:  Sujata Sundara Rajan; Yevgeniy Turovskiy; Yashveer Singh; Michael L Chikindas; Patrick J Sinko
Journal:  J Control Release       Date:  2014-09-16       Impact factor: 9.776

9.  In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories.

Authors:  Brigitte E Beer; Gustavo F Doncel; Fred C Krebs; Robin J Shattock; Patricia S Fletcher; Robert W Buckheit; Karen Watson; Charlene S Dezzutti; James E Cummins; Ena Bromley; Nicola Richardson-Harman; Luke A Pallansch; Carol Lackman-Smith; Clay Osterling; Marie Mankowski; Shendra R Miller; Bradley J Catalone; Patricia A Welsh; Mary K Howett; Brian Wigdahl; Jim A Turpin; Patricia Reichelderfer
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 10.  Cellular targets and mechanisms in the cytotoxic action of non-biodegradable engineered nanoparticles.

Authors:  Eleonore Fröhlich
Journal:  Curr Drug Metab       Date:  2013-11       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.